BOTALYS Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
28
- Latest Deal Type
-
2ndary - Private
- Investors
-
6
BOTALYS General Information
Description
Producer of potent botanicals intended to make the sourcing of rare medicinal plants easy and sustainable. The company uses indoor vertical farming to reproduce and optimize wild-like growth conditions by meticulously setting up each environmental parameter, such as temperature, substrate, and access to nutrients, among others, in an indoor sterile environment, enabling businesses to provide customers with traceable, pure, and bioactive ingredients.
Contact Information
Website
www.botalys.comCorporate Office
- Avenue des Artisans 8 Box 6
- 7822 Ghislenghien
- Belgium
Corporate Office
- Avenue des Artisans 8 Box 6
- 7822 Ghislenghien
- Belgium
BOTALYS Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Later Stage VC (Series B) | 29-Sep-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 14-Jan-2020 | Completed | Generating Revenue | |||
| 5. Grant | 26-Mar-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 09-Jan-2019 | Completed | Generating Revenue | |||
| 3. Grant | 31-May-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 22-Sep-2016 | $560K | $560K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Feb-2016 | Completed | Generating Revenue |
BOTALYS Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class H | ||||||||
| Class H | ||||||||
| Class G | ||||||||
| Class F | ||||||||
| Class D | ||||||||
| Class B | 36,900 | $8.93 | $8.93 | 1x | $8.93 | 1.91% | ||
| Ordinary | 142,500 | $0.72 | $0.72 | 1x | $0.72 | 7.37% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
BOTALYS Patents
BOTALYS Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2022553120-A | Carrot composition and its use as a medicament | Pending | 03-Sep-2019 | ||
| AU-2020342706-A1 | Ginseng composition and use thereof as a medicament | Inactive | 03-Sep-2019 | ||
| EP-4025231-A1 | Ginseng composition and use thereof as a medicament | Active | 03-Sep-2019 | ||
| EP-4025231-B1 | Ginseng composition and use thereof as a medicament | Active | 03-Sep-2019 | ||
| EP-4025231-C0 | Ginseng composition and use thereof as a medicament | Active | 03-Sep-2019 | A61K36/258 |
BOTALYS Signals
BOTALYS Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aliad | Corporation | Minority | ||
| The Yield Lab | Venture Capital | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| European Union | Government | |||
| Horizon 2020 | Government |
BOTALYS Acquisitions (1)
BOTALYS’s most recent deal was a Merger/Acquisition with ROOTec bioactives. The deal was made on 01-Mar-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ROOTec bioactives | 01-Mar-2016 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
BOTALYS FAQs
-
When was BOTALYS founded?
BOTALYS was founded in 2011.
-
Where is BOTALYS headquartered?
BOTALYS is headquartered in Ghislenghien, Belgium.
-
What is the size of BOTALYS?
BOTALYS has 28 total employees.
-
What industry is BOTALYS in?
BOTALYS’s primary industry is Specialty Chemicals.
-
Is BOTALYS a private or public company?
BOTALYS is a Private company.
-
What is BOTALYS’s current revenue?
The current revenue for BOTALYS is .
-
How much funding has BOTALYS raised over time?
BOTALYS has raised $18M.
-
Who are BOTALYS’s investors?
Aliad, The Yield Lab, European Innovation Council, European Union, and Horizon 2020 are 5 of 6 investors who have invested in BOTALYS.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process